Alvine Pharmaceuticals, Inc. Presents Celiac Disease Symptom Frequency and Severity Study Results at the 2012 American College of Gastroenterology Meeting

Published: Oct 24, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Pharmaceuticals, Inc., a leader in celiac disease therapeutics development, today announced the presentation of patient-reported outcomes data at the 2012 American College of Gastroenterology meeting in Las Vegas, NV. The poster presentation included data on the frequency and severity of symptoms experienced by celiac disease patients attempting to adhere to a gluten-free diet. In the study, a disease-specific patient-reported outcome diary was used to collect daily symptom data from celiac disease patients.

Back to news